- Home
- MRBK vs SGMO Comparison
MRBK vs SGMO Comparison
Compare MRBK & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- SGMO
- Stock Information
- Founded
- MRBK 2004
- SGMO 1995
- Country
- MRBK United States
- SGMO United States
- Employees
- MRBK N/A
- SGMO N/A
- Industry
- MRBK Major Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MRBK Finance
- SGMO Health Care
- Exchange
- MRBK Nasdaq
- SGMO Nasdaq
- Market Cap
- MRBK 145.8M
- SGMO 122.8M
- IPO Year
- MRBK 2017
- SGMO 2000
- Fundamental
- Price
- MRBK $13.89
- SGMO $0.49
- Analyst Decision
- MRBK Buy
- SGMO Buy
- Analyst Count
- MRBK 2
- SGMO 6
- Target Price
- MRBK $17.00
- SGMO $4.50
- AVG Volume (30 Days)
- MRBK 115.9K
- SGMO 5.3M
- Earning Date
- MRBK 07-25-2025
- SGMO 08-05-2025
- Dividend Yield
- MRBK 3.61%
- SGMO N/A
- EPS Growth
- MRBK 33.85
- SGMO N/A
- EPS
- MRBK 1.42
- SGMO N/A
- Revenue
- MRBK $101,096,000.00
- SGMO $63,756,000.00
- Revenue This Year
- MRBK $20.44
- SGMO N/A
- Revenue Next Year
- MRBK $10.56
- SGMO N/A
- P/E Ratio
- MRBK $9.77
- SGMO N/A
- Revenue Growth
- MRBK 8.82
- SGMO 239.92
- 52 Week Low
- MRBK $10.04
- SGMO $0.37
- 52 Week High
- MRBK $17.33
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- MRBK 61.70
- SGMO 47.00
- Support Level
- MRBK $13.85
- SGMO $0.50
- Resistance Level
- MRBK $14.33
- SGMO $0.54
- Average True Range (ATR)
- MRBK 0.54
- SGMO 0.05
- MACD
- MRBK 0.21
- SGMO 0.00
- Stochastic Oscillator
- MRBK 86.04
- SGMO 49.35
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.